ATE293986T1 - Schmerzlindernde verwendung von n-l-alpha- aspartyl-l-phenylalanine-1-methylester - Google Patents

Schmerzlindernde verwendung von n-l-alpha- aspartyl-l-phenylalanine-1-methylester

Info

Publication number
ATE293986T1
ATE293986T1 AT96921738T AT96921738T ATE293986T1 AT E293986 T1 ATE293986 T1 AT E293986T1 AT 96921738 T AT96921738 T AT 96921738T AT 96921738 T AT96921738 T AT 96921738T AT E293986 T1 ATE293986 T1 AT E293986T1
Authority
AT
Austria
Prior art keywords
aspartyl
phenylalanine
alpha
methyl ester
pain relieving
Prior art date
Application number
AT96921738T
Other languages
English (en)
Inventor
Allen B Edmundson
Carl V Manion
Original Assignee
Oklahoma Med Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oklahoma Med Res Found filed Critical Oklahoma Med Res Found
Application granted granted Critical
Publication of ATE293986T1 publication Critical patent/ATE293986T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/31—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives
    • A23L27/32—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives containing dipeptides or derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Seasonings (AREA)
AT96921738T 1995-06-23 1996-06-21 Schmerzlindernde verwendung von n-l-alpha- aspartyl-l-phenylalanine-1-methylester ATE293986T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47995P 1995-06-23 1995-06-23
US08/590,409 US5654334A (en) 1995-06-23 1996-01-25 Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester
PCT/US1996/010716 WO1997000692A1 (en) 1995-06-23 1996-06-21 ANALGESIC USE OF N-L-α-ASPARTYL-L-PHENYLALANINE 1-METHYL ESTER

Publications (1)

Publication Number Publication Date
ATE293986T1 true ATE293986T1 (de) 2005-05-15

Family

ID=26667704

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96921738T ATE293986T1 (de) 1995-06-23 1996-06-21 Schmerzlindernde verwendung von n-l-alpha- aspartyl-l-phenylalanine-1-methylester

Country Status (8)

Country Link
US (2) US5654334A (de)
EP (1) EP0833651B1 (de)
JP (1) JP2000502318A (de)
AT (1) ATE293986T1 (de)
AU (1) AU722460B2 (de)
CA (1) CA2225462A1 (de)
DE (1) DE69634662T2 (de)
WO (1) WO1997000692A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654334A (en) * 1995-06-23 1997-08-05 Oklahoma Medical Research Foundation Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester
JP2001505188A (ja) * 1996-09-26 2001-04-17 オゥクラホゥマ、メディカル、リサーチ、ファウンデイシャン Ｎ―Ｌ―α―アスパルチル―Ｌ―フェニルアラニン１―メチルエステル及びその誘導体の疾患後退への使用
US6156795A (en) * 1997-12-22 2000-12-05 Oklahoma Medical Research Foundation N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester and its derivatives for appetite enhancement
US6326400B1 (en) 1999-08-27 2001-12-04 Allen B. Edmundson N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester and its derivatives for appetite enhancement
AUPQ291499A0 (en) * 1999-09-17 1999-10-07 Women's And Children's Hospital Adelaide Novel nitro and sulphur containing compounds
US6919374B1 (en) 1999-09-25 2005-07-19 Oklahoma Medical Research Foundation Viscosity modulating substance and use thereof
EP1218024B1 (de) * 1999-09-25 2006-03-29 Oklahoma Medical Research Foundation Aspartamderivate zur senkung der blutviskosität
JP2005060311A (ja) * 2003-08-13 2005-03-10 Mochida Pharmaceut Co Ltd Ｎ−（ベンゾイル）アミノ酸誘導体を有効成分とするニューロパシー性疼痛治療剤
WO2005107788A1 (en) * 2004-04-27 2005-11-17 Oklahoma Medical Research Foundation Inhibition of allergic contact dermatitis by n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester
US20050277597A1 (en) * 2004-06-10 2005-12-15 Oklahoma Medical Research Foundation Use of N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester to treat sunburn and other burns
PA8720901A1 (es) * 2006-03-24 2008-11-19 Wyeth Corp Tratamiento del dolor
AU2014369916A1 (en) 2013-12-24 2016-06-16 Durect Corporation Uses of oxygenated cholesterol sulfates (OCS)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3492131A (en) * 1966-04-18 1970-01-27 Searle & Co Peptide sweetening agents
US5053396A (en) * 1985-08-27 1991-10-01 Blass David H Therapeutic composition
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
WO1988007892A1 (fr) * 1987-04-09 1988-10-20 Terumo Kabushiki Kaisha Substance de separation de lymphocytes b et substance de clarification de fluides somatiques
JPH0832627B2 (ja) * 1988-02-16 1996-03-29 三井東圧化学株式会社 二日酔予防治療剤
US5053393A (en) * 1988-07-20 1991-10-01 Monsanto Company Novel platelet-aggregation inhibitor
FR2649611A1 (fr) * 1989-07-13 1991-01-18 Philippe Perovitch Procede de preparation galenique d'une composition therapeutique notamment a base d'aspirine
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica
BE1007099A5 (fr) * 1993-11-22 1995-03-14 Messadek Jallal Activite medicamenteuse de l'aspartame.
FR2714064B1 (fr) * 1993-12-16 1996-03-08 Edmond Creppy Aspartame pour son application en tant que substance thérapeutiquement active.
US5654334A (en) * 1995-06-23 1997-08-05 Oklahoma Medical Research Foundation Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester

Also Published As

Publication number Publication date
DE69634662D1 (de) 2005-06-02
WO1997000692A1 (en) 1997-01-09
EP0833651A1 (de) 1998-04-08
DE69634662T2 (de) 2006-03-02
JP2000502318A (ja) 2000-02-29
AU6287896A (en) 1997-01-22
US5654334A (en) 1997-08-05
CA2225462A1 (en) 1997-01-09
EP0833651B1 (de) 2005-04-27
AU722460B2 (en) 2000-08-03
US5998473A (en) 1999-12-07

Similar Documents

Publication Publication Date Title
US5091171B1 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
IL76932A (en) Synergistic pharmaceutical analgesic compositions containing dihydrocodeine and ibuprofen
BR9206631A (pt) Sistema de maior penetração na pele para melhor administração tópica de medicamentos
DE122011000009I1 (de) Verbesserte arzneiverabreichung an schleimhautoberflächen
DE69634662D1 (de) Schmerzlindernde verwendung von n-l-alpha-aspartyl-l-phenylalanine-1-methylester
DE69735848D1 (de) Dosisform mit ansteigender dosisfreisetzung
CA2274074A1 (en) Novel compounds with analgesic effect
CA2150937A1 (en) Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
CA2239174A1 (en) Novel compounds with analgesic effect
TW352384B (en) Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals
AU6414994A (en) Composition and method for reducing toxicity of biologically-active factors
SI1572167T1 (sl) Transdermalni buprenorfinski dozirni reĹľim za analgezijo
AU8970198A (en) N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in thetreatment of pain
DE69531098D1 (de) Piperidine und pyrrolidine
ATE164159T1 (de) Substituierte triole
NO995229D0 (no) Anvendelse av sinkhyaluronat mot peptisk ulcus
TR199701520T1 (xx) Ac�n�n iyile�tirilmesi i�in analjesik bile�ikleri �reten h�cre soyu.
MY127711A (en) Anti-vaginitis compositions for topical use
BR9508671A (pt) Método de alívio da dor e composição terapêutica
EA199800866A1 (ru) Способ снятия боли
IL114382A (en) Lymphotoxin for use as a medicament for cancer therapy and use thereof in the manufacture of such medicament
AU7735698A (en) Methods and compositions for treating pain
ITMI921556A0 (it) Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circadiani
EP0906757A3 (de) Analgetische Zusammensetzung welche Moxonidine und ein Opioid-Analgetika enthält
ATE247965T1 (de) Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties